Source:http://linkedlifedata.com/resource/pubmed/id/16621546
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2006-6-1
|
pubmed:abstractText |
A novel series of 2-(1,2,4-oxadiazol-5-yl)-1H-indole derivatives as nociceptin/orphanin FQ (N/OFQ) receptor antagonists was discovered. Systematic modification of our original lead by changing the pendant functional groups, linker, heterocyclic core, and basic side chain revealed the structure-activity requirements for this novel template and resulted in the identification of more potent analog with improved potency as compared to the parent compound.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3569-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16621546-Animals,
pubmed-meshheading:16621546-Binding Sites,
pubmed-meshheading:16621546-CHO Cells,
pubmed-meshheading:16621546-Cell Membrane,
pubmed-meshheading:16621546-Cricetinae,
pubmed-meshheading:16621546-Drug Design,
pubmed-meshheading:16621546-Drug Evaluation, Preclinical,
pubmed-meshheading:16621546-Humans,
pubmed-meshheading:16621546-Indoles,
pubmed-meshheading:16621546-Molecular Structure,
pubmed-meshheading:16621546-Receptors, Opioid,
pubmed-meshheading:16621546-Stereoisomerism,
pubmed-meshheading:16621546-Structure-Activity Relationship
|
pubmed:year |
2006
|
pubmed:articleTitle |
Design, synthesis, and biological evaluation of indole derivatives as novel nociceptin/orphanin FQ (N/OFQ) receptor antagonists.
|
pubmed:affiliation |
Banyu Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd, Okubo-3, Tsukuba 300-2611, Ibaraki, Japan. yuichi_sugimoto@merck.com
|
pubmed:publicationType |
Journal Article,
Comparative Study
|